Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

PA 2 > midterm 2 > Flashcards

midterm 2 Flashcards

1
Q

Drug solubility In pharmaceutical solutions both the ___ and the ___ are legally required to be present in solution over the shelf-life of the formulated product.

A

THERAPEUTIC AGENTS
EXCIPIENTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The dissolution of a therapeutic agent in water involves several key molecular steps:

A

REMOVAL OF A MOLECULE OF THE DRUG FROM THE SOLID STATE

FORMATION OF A CAVITY WITHIN THE SOLVENT

ACCOMMODATION OF THE DRUG MOLECULE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

breakage of solute-solute and solvent-solvent bonds

A

ENDOTHERMIC PROCESSES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

It occurs whenever the Gibb’s free energy of the process is NEGATIVE and involves a balance between the enthalpy of dissolution and the associated entropy at the temperature of dissolution (T).

A

DISSOLUTION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

It is a thermodynamic potential that measures the maximum amount of reversible work that can be performed by a thermodynamic system at constant temperature and pressure.

A

GIBB’S FREE ENERGY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Refers to the thermodynamic capacity of API.

A

ENTHALPY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Refers to the m easurement of the degree of randomness or spontaneity of API.

A

ENTROPY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Factors affecting the solubility of therapeutic agents:

A

• molecular weight
• Volume
• radius of gyration Density
• number of rotatable bonds
• hydrogen bond donors and
• hydrogen bond acceptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

as the melting point of the therapeutic agent is increased, the solubility would be expected to decrease

A

INVERSELY RELATED TO THEIR MELTING POINTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

It is directly affected by both the type of chemical substituent groups and the substituent position.

A

THERAPEUTIC AGENT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

thesolubilitiesoftherapeuticagentsthatareeitheracidsorbases (representing the vast majority of drug substances) are __

A

pH-DEPENDENT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

are physiologically inert compounds.

A

EXCIPIENTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

It facilitates the administration of the dosage form, e.g. pourability, palatability

A

EXCIPIENTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

• protect the formulation from issues regarding physical and chemical stability
• enhance the solubility of the therapeutic agent.

A

EXCIPIENTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

It is commonly used due to the low cost and low toxicity of this ingredient.

A

PURIFIED WATER, USP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

■ It is prepared by distillation, ion exchange methods or by reverse osmosis.
■ The solid residue (obtained after evaporation) is less than 1 mg per 100 ml of evaporated sample.

A

PURIFIED WATER, USP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

■ It must not be used for the preparation of parenteral formulations.

A

PURIFIED WATER, USP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

It is an odorless, sweet liquid that is miscible with water and whose co-solvency properties are due to the presence of three hydroxyl groups (termed a triol).

A

GLYCEROL (GLYCERIN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

It has similar co-solvency properties to ethanol.

A

GLYCEROL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

It contains between 94.9 and 96.0% v/v ethyl alcohol (ethanol) and is commonly used as a co-solvent, both as a single co-solvent and with other co-solvents, e.g. glycerol

A

ALCOHOL USP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

It is an odourless, colourless, viscous liquid diol that contains two hydroxyl groups. It is used in pharmaceutical preparations as a co-solvent, generally as a replacement for glycerin.

A

PROPYLENE GLYCOL USP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

It is a polymer composed of repeating units of the monomer ethylene oxide, Lower-molecular-weight grades (PEG 200, PEG 400) are preferred as co-solvents in pharmaceutical solutions

A

POLY(ETHYLENE GLYCOL) PEG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

These are chemicals that possess both hydrophilic (water-liking) and hydrophobic (water-disliking) regions.

A

SURFACE-ACTIVE AGENTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

It would prevent drug absorption across biological membranes

A

DRUG-POLYMER COMPLEX

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

These are employed within pharmaceutical solutions to control the pH of the formulated product and, in so doing, optimise the physicochemical performance of the product.

A

BUFFERS

26
Q

Examples of buffer salts used in pharmaceutical solutions

A
  • ACETATES (ACETIC ACID AND SODIUM ACETATE)
  • CITRATES (CITRIC ACID AND SODIUM CITRATE)
  • PHOSPHATES (SODIUM PHOSPHATE AND DISODIUM PHOSPHATE)
27
Q

are employed in liquid formulations designed for oral administration specifically to increase the palatability of the therapeutic agent.

A

SWEETENING AGENTS

28
Q

The main sweetening agents employed in oral preparations are:

A

SUCROSE
LIQUID GLUCOSE
GLYCEROL
SORBITOL
SACCHARIN SODIUM
ASPARTAME

29
Q

It is used either as the sole sweetening agent or in combination with sugars or sorbitol to reduce the sugar concentration in the formulation.

A

SACCHARIN SODIUM

30
Q

The administration of oral solutions to patients is usually performed using a

A

SYRINGE
SMALL-METERED CUP
TRADITIONAL 5-ML SPOON

31
Q

The viscosity of pharmaceutical solutions may be easily increased (and controlled) by the:

A

ADDITION OF NON-IONIC OR IONIC HYDROPHILIC POLYMERS

32
Q

cellulose derivatives

A

NON-IONIC (NEUTRAL) POLYMERS

33
Q

examples of non ionic (neutral) polymers

A

METHYLCELLULOSE
HYDROXYETHYLCELLULOSE
HYDROXYPROPYLCELLULOSE

34
Q

polyvinylpyrrolidone

A

HYDROXYPROPYLCELLULOSE

35
Q

sodium carboxymethylcellulose (anionic) – sodium alginate (anionic)

A

IONIC POLYMERS

36
Q

These are molecules that are redox systems that exhibit higher oxidative potential than the therapeutic agent or, alternatively, are compounds that inhibit free radical-induced drug decomposition.

A

ANTIOXIDANTS

37
Q

Examples of antioxidants that may be used in oil-based solutions include:

A

BUTYLATED HYDROXYTOLUENE (BHT)
BUTYLATED HYDROXYANISOLE (BHA)
PROPYL GALLATE

38
Q

These are included in pharmaceutical solutions to control the microbial bioburden of the formulation.

A

PRESERVATIVES

39
Q

These are employed whenever the unpalatable taste of a therapeutic agent is apparent, even in the presence of the sweetening agents.

A

FLAVORS

40
Q

These are generally natural or synthetic water soluble, photo-stable ingredients that are selected according to the flavour of the preparation.

A

COLOURS

41
Q

These are viscous preparations that contain the therapeutic agent dissolved in a vehicle composed of a high percentage of sucrose and, if required, other sweetening agents.

A

LINCTUSES

42
Q

It occurs whenever the Gibb’s free energy of the process is negative and involves a balance between the enthalpy of dissolution and the associated entropy at the temperature of dissolution (T).

A

DISSOLUTION

43
Q

Oral Liquid Dosage Forms

A

SYRUP
ORAL SOLUTION
ORAL DROP
ORAL EMULSION
MIXTURE
LINCTUSES
ELIXIR

44
Q

The aqueous solubility of the therapeutic agent is _____ of the formulation. Under these circumstances the therapeutic agent may be ______ and formulated as an oral solution.

A
  • high at the selected pH
  • readily incorporated into the vehicle
45
Q

The aqueous solubility of the therapeutic agent is _____ of the formulation, i.e. the aqueous solubility is less than the requested concentration of therapeutic agent.

A
  • moderate at the selected pH
46
Q

Example of alternative-dosage form

A

SUSPENSION

47
Q

commonly employed co-solvents

A

GLYCEROL
PROPYLENE GLYCOL
ETHANOL
POLY(ETHYLENE GLYCOL)

48
Q

most commonly used vehicle for oral administration

A

PURIFIED WATER USP

49
Q

Control of the pH in the formulation is achieved using a buffer that does not adversely affect the solubility of the therapeutic agent.

A
50
Q

solubility of acidic compounds increases as the pH of the solution is increased (above the pKa) and the solubility of basic compounds increases as the pH is lowered below the pKa.

A
51
Q

these are preferred due to the lack of toxicity of water as the vehicle

A

AQUEOUS SOLUTIONS

52
Q

The solid residue (obtained after evaporation) of purified water usp is

A

less then 1mg per 100 ml of evaporated sample

53
Q

main co-solvents used in the formulation of oral solutions

A

GLYCEROL (GLYCERIN)
ALCOHOL USP (CH3CH2OH)
PROPYLENE GLYCOL USP
POLY(ETHYLENE GLYCOL) PEG
SURFACE-ACTIVE AGENTS
DRUG-POLYMER COMPLEX

54
Q

increasing the viscosity of some formulations may increase the palatability.

A

VISCOSITY-ENHANCING AGENTS

55
Q

It may be easily increased (and controlled) by the addition of non-ionic or ionic hydrophilic polymers.

A

VISCOSITY OF PHARMACEUTICAL SOLUTIONS

56
Q

it possess a broad spectrum of antimicrobial activity encompassing Gram-positive and Gram-negative bacteria and fungi

A

PRESERVATIVES

57
Q

be chemically and physically stable over the shelf-life of the product

have low toxicity.

A

PRESERVATIVES

58
Q

preservatives available for use in pharmaceutical solutions for oral use

A

BENZOIC ACID AND SALTS (0.1 to 0.3%)
SORBIC ACID AND SALTS (0.05 to 0.2%)
ALKYL ESTERS AND PARAHYDROXYBENZOIC ACID (0.001 to 0.2%)

59
Q

liquid products to be used as injections, eye drops or vaccines sterility, these tests are necessary as additional tests.

A

APYROGENICITY TESTING
PARTICULATE MATTER TESTING

60
Q

It refers to the property of a substance or a product that is free from pyrogens

A

Apyrogenicity

61
Q

are substance that can induce Fever when introduced into the body.

They are often bacterial endotoxins, which are components of the cell wall of Gram-negative bacteria

A

Pyrogens

PA 2 (9 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions